DLG5 expression was downregulated in many human cancers, such as bladder cancer, prostate cancer, breast cancer, and hepatocellular carcinoma, not only that, knockdown of DLG5 significantly increased cell migration and invasion in these cancers19,20. Here, DLG5 is linked to prostate cancer.